Wall Street Analysts See a 78.77% Upside in ARS Pharmaceuticals, Inc. (SPRY): Can the Stock Really Move This High?

ARS Pharmaceuticals, Inc. (SPRY) closed the last trading session at $17.9, gaining 18.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $32 indicates a 78.8% upside potential.The average comprises five short-term price targets ranging from a low of $28.00 to a high of $40.00, with a standard deviation of $4.69. While the lowest estimate indicates an increase of 56.4% from the curr ...